Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 18 | 2025 | 716 | 2.080 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 5 | 2018 | 55 | 1.010 |
Why?
|
| Viral Tropism | 5 | 2018 | 51 | 0.850 |
Why?
|
| Macrophages | 12 | 2018 | 1039 | 0.840 |
Why?
|
| CD4 Antigens | 11 | 2023 | 149 | 0.830 |
Why?
|
| HIV Envelope Protein gp120 | 9 | 2018 | 133 | 0.760 |
Why?
|
| HIV Infections | 10 | 2025 | 962 | 0.660 |
Why?
|
| Receptors, CCR5 | 6 | 2018 | 59 | 0.520 |
Why?
|
| Brain | 7 | 2018 | 1550 | 0.510 |
Why?
|
| AIDS Dementia Complex | 2 | 2006 | 10 | 0.490 |
Why?
|
| HIV Antibodies | 6 | 2018 | 144 | 0.480 |
Why?
|
| HIV-2 | 3 | 2013 | 23 | 0.480 |
Why?
|
| Viral Load | 2 | 2013 | 229 | 0.440 |
Why?
|
| Preservation, Biological | 1 | 2013 | 5 | 0.410 |
Why?
|
| Virion | 4 | 2025 | 121 | 0.380 |
Why?
|
| Lymph Nodes | 4 | 2011 | 222 | 0.380 |
Why?
|
| Virus Internalization | 2 | 2009 | 87 | 0.340 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1005 | 0.340 |
Why?
|
| Tropism | 2 | 2006 | 16 | 0.320 |
Why?
|
| HIV Fusion Inhibitors | 1 | 2008 | 9 | 0.290 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2025 | 26 | 0.290 |
Why?
|
| Semen | 1 | 2006 | 44 | 0.250 |
Why?
|
| ADAM10 Protein | 1 | 2025 | 11 | 0.240 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 77 | 0.230 |
Why?
|
| Gene Products, env | 1 | 2004 | 17 | 0.230 |
Why?
|
| Genetic Variation | 1 | 2006 | 370 | 0.220 |
Why?
|
| Cell Line | 6 | 2023 | 2038 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 515 | 0.200 |
Why?
|
| Membrane Proteins | 2 | 2025 | 889 | 0.190 |
Why?
|
| Virus Cultivation | 2 | 2013 | 19 | 0.170 |
Why?
|
| Global Burden of Disease | 1 | 2018 | 13 | 0.150 |
Why?
|
| Noncommunicable Diseases | 1 | 2018 | 18 | 0.150 |
Why?
|
| Particulate Matter | 1 | 2018 | 65 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2015 | 2154 | 0.140 |
Why?
|
| Air Pollutants | 1 | 2018 | 93 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 106 | 0.140 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 138 | 0.130 |
Why?
|
| Humans | 19 | 2025 | 62678 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 3 | 2018 | 207 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2018 | 219 | 0.130 |
Why?
|
| Virus Replication | 3 | 2025 | 318 | 0.130 |
Why?
|
| Neutralization Tests | 3 | 2018 | 122 | 0.120 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2025 | 28 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2025 | 641 | 0.110 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2005 | 59 | 0.110 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2005 | 79 | 0.110 |
Why?
|
| Receptors, HIV | 1 | 2012 | 15 | 0.100 |
Why?
|
| Virus Attachment | 1 | 2012 | 18 | 0.100 |
Why?
|
| Amino Acid Substitution | 3 | 2009 | 239 | 0.100 |
Why?
|
| HeLa Cells | 3 | 2010 | 533 | 0.090 |
Why?
|
| Amino Acid Sequence | 4 | 2010 | 1594 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2010 | 1992 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2010 | 173 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 2018 | 411 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 89 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2012 | 866 | 0.070 |
Why?
|
| Arginine | 1 | 2008 | 122 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2008 | 142 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2006 | 193 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 334 | 0.060 |
Why?
|
| CCR5 Receptor Antagonists | 1 | 2005 | 16 | 0.060 |
Why?
|
| Cell Fusion | 1 | 2004 | 37 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 49 | 0.050 |
Why?
|
| Protein Binding | 3 | 2018 | 1601 | 0.050 |
Why?
|
| Infant | 1 | 2008 | 1602 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 618 | 0.050 |
Why?
|
| HIV | 1 | 2003 | 70 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2006 | 1341 | 0.050 |
Why?
|
| Phenotype | 1 | 2004 | 1191 | 0.040 |
Why?
|
| Adult | 2 | 2008 | 16625 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 321 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 669 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2010 | 298 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2018 | 73 | 0.040 |
Why?
|
| Air Pollution | 1 | 2018 | 36 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2018 | 119 | 0.040 |
Why?
|
| Genes, env | 1 | 2017 | 15 | 0.040 |
Why?
|
| Phylogeny | 1 | 2018 | 366 | 0.030 |
Why?
|
| Global Health | 1 | 2018 | 182 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 85 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2018 | 174 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 179 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 726 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 669 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 463 | 0.030 |
Why?
|
| Animals | 3 | 2011 | 20579 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 837 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2539 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 2039 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2011 | 45 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 3742 | 0.020 |
Why?
|
| Immunization | 1 | 2011 | 133 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 700 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 332 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 247 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 185 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 139 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 245 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 364 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 260 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 1180 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 453 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 33 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 900 | 0.020 |
Why?
|
| Kidney | 1 | 2008 | 444 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 29 | 0.020 |
Why?
|
| Male | 1 | 2006 | 29483 | 0.010 |
Why?
|
| Amides | 1 | 2005 | 56 | 0.010 |
Why?
|
| Female | 1 | 2006 | 32488 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 318 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 108 | 0.010 |
Why?
|
| Monocytes | 1 | 2005 | 353 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 369 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2003 | 36 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 431 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 277 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2003 | 248 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 248 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 774 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 2573 | 0.010 |
Why?
|